DERMA PHARM A/S: Financial statements 2016
CVR: 89453119
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 43,171,388 and a net result of DKK 7,769,435 compared with DKK 4,334,578 the year before. That is an increase of 29.5% compared with the year before. Equity in the 2016 report amounted to DKK 22,401,216. The solvency ratio was 38.9%. The company had 62 employees in the financial year.
- Gross Profit
- DKK 43,171,388
- Profit/Loss
- DKK 7,769,435
- Equity
- DKK 22,401,216
- Total Assets
- DKK 57,583,809
- Employees
- 62
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 43.2 mio. | 7.8 mio. | 22.4 mio. | 62 |
| 2015 | - | 33.3 mio. | 4.3 mio. | 14.6 mio. | 56 |
| 2014 | - | 24.2 mio. | -4.3 mio. | 10.3 mio. | - |
| 2013 | - | 29.8 mio. | 1.6 mio. | 14.6 mio. | - |
| 2012 | - | 19.4 mio. | 1.1 mio. | 15.7 mio. | - |
Official annual report
Find more companies like DERMA PHARM A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
DERMA PHARM A/S has published its annual report for 2015. Gross profit came to DKK 33,330,278, and the net result was DKK 4,334,578.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.